Section 34

EurekaMag Full Text Articles Chapter 33,691


Gidon Maurice 1972: The Brianconnais and sub-Brianconnais chains of the left margin of the Stura di Demonte in the Val de lArma, Cuneo, Italy. Geologie Alpine 48(1): 87-120
Gidon Maurice 1967: The Brianconnais zone south of Guillestre Hautes-Alpes; the Vars mountains Embrun and Gap quadrangles. Bulletin du Service de la Carte Geologique de la France 61(278): 163-184
Anselmetti, S.; Poletti, S.; Ermoli, E.; Bechi, M.; Cappa, S.; Venneri, A.; Smeraldi, E.; Cavallaro, R. 2008: The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 29(2): 85-92
Downs, T.M.; Loughlin, K.R.; Bosch, R.; O'leary, M.P.; Kumar, S.; Renshaw, A.A.; Richie, J.P. 1998: The Brigham and Womens Hospital experience with T1C cancer of the prostate A two year retrospective review. Journal of Urology 159(5 Suppl): 182
Garreau, B. 1995: The Brion archaeological site, town of Saint Germain dEsteuil. Bulletin de la Societe Linneenne de Bordeaux 23(2): 53-55
Scoz, N.; Pomata, D.; Bagnoli, M.; Fedeli, S.; Dormi, A.; Gaddi, A. 1995: The Brisighella Heart Study An evolution of antihypertensive therapy in a small rural community. European Journal of Clinical Investigation 25(Suppl 2): A17
Descovich, G.C.; Dormi, A.; Sangiorgi, Z.; Stuart, K. 1993: The Brisighella Heart Study Triglycerides as a predictor for coronary heart disease. European Journal of Clinical Investigation 23(Suppl 1): A45
Van Der Weyden, M.B. 1998: The Bristol case, the medical profession and trust. Medical Journal of Australia 169(7): 352-353
Spencer, I.C.; Spry, P.G.; Gray, S.F.; Baker, I.A.; Menage, M.J.; Easty, D.L.; Sparrow, J.M. 1995: The Bristol Shared Care Glaucoma Study: study design. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 15(5): 391-394
Mccandless, R.G. 1997: The Britannia Mines problem Rocks, architecture and footprint. AAAS Annual Meeting and Science Innovation Exposition 163: A41
Witherby, H.F. 1927: The British Birds marking scheme Progress for 1926. British Birds: 236-250
Witherby, H.F. 1931: The British Birds marking scheme Progress for 1930. British Birds 24(9): 234-244
Hawkins, M.M.; Lancashire, E.R.; Winter, D.L.; Frobisher, C.; Reulen, R.C.; Taylor, A.J.; Stevens, M.C.G.; Jenney, M. 2008: The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatric Blood and Cancer 50(5): 1018-1025
Dix, D.; Goddard, K.; Fryer, C.; Steinbok, P.; Parsons, C.; Rheaume, D. 1996: The British Columbia experience A review of 25 paediatric cases of intracranial ependymoma. Clinical and Investigative Medicine 19(4 Suppl): S86
Attridge, J.; Ball, H.W.; Charig, A.J.; Cox, C.B. 1964: The British Museum Natural History-University of London Joint Palaeontological Expedition to Northern Rhodesia and Tanganyika, 1963. Nature (London) 201(4918): 445-449
Foot, B.G.; Stanford, M.R. 1998: The British Ophthalmological Surveillance Unit. IOVS Investigative Ophthalmology and Visual Science 39(4): S843
Symmons, D.P.M.; Stewart, O.J.; Sills, J.; Southwood, T.R.; Woo, P. 1993: The British Paediatric Rheumatology Group national diagnostic index. Journal of Rheumatology 20(Suppl 37): 62
Colvin, B.T.; Barrowcliffe, T.W. 1993: The British Society for Haematology Guidelines on the use and monitoring of heparin 1992 Second revision. Journal of Clinical Pathology 46(2): 97-103
Redgate, N.D. 1996: The British checklist of Menacanthus Neumann, 1912 , with particular reference to those species found on the Passeriformes. Entomologist's Monthly Magazine 132(1580-1583): 69-71
Wood, D.A.; Kinmonth, A.L.; Pyke, S.D.M.; Thompson, S.G. 1994: The British family heart study Principal results of a trial of cardiovascular screening in primary care. European Heart Journal 15(ABSTR Suppl ): 171
Whitehead, P.F. 1998: The British records of Eurysa brunnea Melichar, 1896. Entomologist's Monthly Magazine 134(1612-1615): 307-310
Hayward, P.J.; Ryland, J.S. 1995: The British species of Schizoporella. Journal of Zoology (London) 237(1): 37-47
Lebour, M.V. 1933: The British species of Trivia T arctica and T monacha. Jour Marine Biol Assoc United Kingdom 18(2): 477-484
Malik, K.F.; Young, W.S.IIi 1995: The Brn-4 POU domain mediates protein-protein interactions between Brn-4 and other class III POU factors. Society for Neuroscience Abstracts 21(1-3): 1260
Meregalli, M. 1999: The Bromeliad collection in the Botanic Garden of Torino. Allionia (Turin) (36): 97-100, Aug , 1998-
Johnson, E.D. 1994: The Brookhaven National Laboratory deep ultraviolet free-electron laser. Photochemistry and Photobiology 59(SPEC ISSUE): 41S
Dosik, H.; Levine, P.H.; Dussek, N.; Orav, E.J.; Landesman, S.; Manns, A.; Welles, S.L. 1995: The Brooklyn HTLV-I study Design considerations. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(2): 266
Floater, G.J. 1996: The Brooks-Dyar rule and morphometrics of the processionary caterpillar Ochrogaster lunifer Herrich-Schaffer. Australian Journal of Entomology 35(3): 271-278
Gilbert, P.W. 1942: The Brown Jays furcular pouch. Condor: 160-165
Naai, M.A.; Gruenewald, D.A.; Hess, D.L.; Matsumoto, A.M. 1993: The Brown Norway rat as an ideal model for reproductive aging Evidence for primary and secondary testicular failure. Clinical Research 41(1): 58A
Jordana, J.; Piedrafita, J. 1996: The Bruna dels Pirinieus A genetic study of a rare cattle breed in Catalonia. Biochemical Systematics and Ecology 24(6): 485-498
D.H.rt, M.; Thys, E.; Vercruyssen, V.; Peuskens, J. 1994: The Brussels Night Hospital A 3 year follow-up study. Schizophrenia Research 11(2): 174
Durinck, J.; Barahona, P. 1994: The Brussels Seminar. Barahona, P, Christensen, J P Studies in Health Technology and Informatics; Knowledge and decisions in health telematics 221-227
Bonini, I. 1994: The Bryological Collections of the Herbarium Universitatis Senensis. Informatore Botanico Italiano 25(2-3): 268-271
Ristedt, H. 1995: The Bryozoa fauna of the eastern Weddell Sea. Berichte zur Polarforschung 1995(155): 75-78
Neely, R.K.; Roberts, R.J. 2008: The BsaHi restriction-modification system: cloning, sequencing and analysis of conserved motifs. Bmc Molecular Biology 9: 48
Savader, S.J. 1996: The Budd-Chiari syndrome. Savader, S J, Trerotola, S O Venous interventional radiology with clinical perspectives: 62-88
Langnas, A.N.; Sorrell, M.F. 1993: The Budd-Chiari syndrome: a therapeutic Gordian knot?. Seminars in Liver Disease 13(4): 352-359
Mishra, C.G. 1994: The Budhikhamari model of participatory management of the forest eco-system in Orissa. Indian Forester 120(7): 597-601
Fenton, T.W. 1997: The Buhl woman A Paleoindian skeleton from southern Idaho. American Journal of Physical Anthropology 1997(Suppl 24): 110
Leventhal, J.S.; Merkel, S.M.; Chazan, A.M.; Kachlany, S.C. 1998: The Bulging Cannes Biofilm Festival A Web-based exploratory activity on biofilms. Abstracts of the General Meeting of the American Society for Microbiology 98: 539
Crawford John, E.; Padan John, W. 1965: The Bureau of Mines expanding role in undersea mining. Mining Engineering 17(3): 67-69
Perier,H.; Besancon,G.; Macaire,A. 2008: The Burgundy truffle, an opportunity for the limestone plateaux of the Haute-Soane. Rendez Vous Techniques: , 73-76
Depippo, K.L.; Holas, M.A.; Reding, M.J. 1993: The Burke Screening Test for Dysphagia Validation of its use in patients with stroke. Stroke 24(1): 173
Takada, K. 1998: The Burkitts lymphoma line Akata. Osato, T , Takada, K , Tokunaga, M Gann Monograph on Cancer Research; Epstein-Barr virus and human cancer 19-28
Nikko, A.; Kaneishi, N.; Dano, J.; Cockerell, C. 1996: The Buschke-Ollendorf syndrome A case report and review of the literature. Journal of Cutaneous Pathology 23(1): 86
Smith, D.S.; Ramos, S.J.; Mckenzie, F. 1994: The Butterflies of Mona Island and an Approach to Their Origins and Phenology. Caribbean Journal of Science 30(1-2): 95-103
Levetown, M. 1997: The Butterfly Program A template for institutional change in the care of children living with life-threatening illness-progress and problems. Pediatrics 100(3 Part 2): 456
Cotter, P.A.; Miller, J.F. 1994: The Bvg+ phase is necessary and sufficient for establishment of infection and short-term colonization of the rabbit respiratory tract. Abstracts of the General Meeting of the American Society for Microbiology 94: 97
Akerley, B.; Miller, J.F. 1994: The BvgAS controlled motility regulon in Bordetella. Abstracts of the General Meeting of the American Society for Microbiology 94: 97
Liu, M.; Cotter, P.A.; Miller, J.F. 1998: The BvgAS system appears to regulate alternative cytochrome oxidases in Bordetella species. Abstracts of the General Meeting of the American Society for Microbiology 98: 65
Hueston, J.L.; Herren, G.P.; Cueva, J.G.; Buechner, M.; Lundquist, E.A.; Goodman, M.B.; Suprenant, K.A. 2008: The C. elegans EMAP-like protein, ELP-1 is required for touch sensation and associates with microtubules and adhesion complexes. Bmc Developmental Biology 8: 110
Woo, W.-M.; Berry, E.; Hudson, M.L.; Swale, R.E.; Goncharov, A.; Chisholm, A.D. 2008: The C. elegans F-spondin family protein SPON-1 maintains cell adhesion in neural and non-neural tissues. Development 135(16): 2747-2756
Kanazawa, T.; Zappaterra, M.D.; Hasegawa, A.; Wright, A.P.; Newman-Smith, E.D.; Buttle, K.F.; McDonald, K.; Mannella, C.A.; van der Bliek, A.M. 2008: The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals. Plos Genetics 4(2): E1000022
Liu, J.; Phillips, B.T.; Amaya, M.F.; Kimble, J.; Xu, W. 2008: The C. elegans SYS-1 protein is a bona fide beta-catenin. Developmental Cell 14(5): 751-761
Larsen, P.L.; Yeh, W.H.; Albert, P.S.; Riddle, D.L. 1994: The C elegans daf-12 gene encodes a member of the steroid/thyroid hormone receptor superfamily and interacts with daf-2 mutations to determine life span. Journal of Cellular Biochemistry Suppl 1994(18B): 381
Riddle, D.L.; Lim, C.S.; Johnsen, R.; Estevez, M.; Albert, P.S.; Pilgrim, D. 1994: The C elegans daf-7 genes encodes a new member of the transforming growth factor-beta superfamily that is a putative ligand fore the daf-1 receptor. Journal of Cellular Biochemistry Suppl 1994(18B): 244
Bernard, V.; Roggo, L.; Mueller, F.; Wymann, M. 1996: The C elegans phosphatidylinositol 3-kinase. Experientia 52(ABSTR ): A37
Rand, J.B.; Alfonso, A.; Duerr, J.; Grundahl, K.; Han, H.P.ng 1993: The C elegans unc-17 gene encodes a putative vesicular acetylcholine transporter. Society for Neuroscience Abstracts 19(1-3): 4
Lockwood, C.; Zaidel-Bar, R.; Hardin, J. 2008: The C. elegans zonula occludens ortholog cooperates with the cadherin complex to recruit actin during morphogenesis. Current Biology: Cb 18(17): 1333-1337
Temasamani, J.; Mayrand, S.H.; Pederson, T. 1996: The C hnRNP proteins bind to the 5 stem-loop of the U2 small nuclear ribonucleoprotein particle. Molecular Biology of the Cell 7(Suppl ): 628A
Boyd, J.D.; Matsubara, J.A. 1993: The C laminae of the cat lateral geniculate selectively target cytochrome oxidase blobs in area 17. Society for Neuroscience Abstracts 19(1-3): 334
Sleeman, K.; Bankamp, B.; Hummel, K.B.; Lo, M.K.; Bellini, W.J.; Rota, P.A. 2008: The C, V and W proteins of Nipah virus inhibit minigenome replication. Journal of General Virology 89(Part 5): 1300-1308
Carreer, F.M. 1992: The C1 inhibitor deficiency. A review. European Journal of Clinical Chemistry and Clinical Biochemistry 30(12): 793-807
Yokosawa, J.; Dijkwel, P.A.; Soares, M.A.bertina M.; Stocker, A.J.; Hamlin, J.L.; Lara, F.J.S. 1997: The C-3 DNA puff of Rhynchosciara americana Searching for the origin. Hereditas (Lund) 127(3): 265-266
Penalva, L.O.F.; Yokosawa, J.; Stocker, A.J.; Soares, M.A. M.; Graessmann, M.; Orlando, T.C.; Winter, C.E.; Botella, L.M.; Graessmann, A.; Lara, F.J.S. 1997: The C-3 DNA puff of Rhynchosciara americana The transcription unit and levels of amplification. Hereditas (Lund) 127(3): 265
Koch, K.; Newborg, M.F.; Hanson, D.C.; Cooper, K.; Shepard, R.M.; Biehl, M.L.; Biggers, M.S.; Ramchandani, M.; Schulte, G.; Snyder, J.R. 1995: The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant. Journal of Medicinal Chemistry 38(8): 1255-1258
Koh, N.; Sakakibara, F.; Nakamura, J.; Hamada, Y.; Hara, T.; Wakao, T.; Mori, K.; Sasaki, H.; Nakashima, E.; Naruse, K.; Hotta, N. 1995: The C-64 tuning fork A quantitative evaluation method for diabetic neuropathy. Hotta, N , Greene, D A , Ward, J D , Sima, A A F , Boulton, A J M International Congress Series; Diabetic neuropathy: New concepts and insights 333-336
Beauchemin, N.; Sadekova, S.; Huber, M.; Izzi, L.; Turbide, C. 1998: The C-CAM protein acts as a tumour suppressor and a signal transducer. Tumor Biology 19(Suppl 2): 3
Holm, J.; Hillenbrand, R.; Steuber, V.; Montag, D.; Moos, M.; Schachner, M. 1994: The C-DNA of CH-L1, a novel member of the L1CAM immunoglobulin superfamily in mice. Experientia (Basel) 50(ABSTR ): A60
Schaefer, C.; Holz, A.; Schaeren Wiemers, N.; Schwab, M.E. 1993: The C-DNA of COP, a novel oligodendrocyte specific protein. Experientia 49(ABSTR ): A66
Rustgi, A.K.; Hateboer, G.; Bernards, R. 1993: The C-MYC oncoprotein binds to the tata-binding protein in vitro and in vivo. Gastroenterology 104(4 Suppl): A445
LiuChunMing; WeiWenJuan; RenBingZhong; LiNa; YuanHaiBin 2008: The C-banding karyotype of chromosome in Teleogryllus derelictus. Journal Of Jilin Agricultural University: 6, 789-792
Beebe, S.J.; Salomonsky, P.M.; Uhler, M.D. 1993: The C-gamma and C-alpha-subunits of the CAMP-dependent protein kinases have different inhibitor sensitivities. FASEB Journal 7(3-4): A833
Pouly, S.; Storch, M.; Matthieu, J.M.; Lassmann, H.; Honegger, P. 1995: The C-kinase activator mezerein induces dedifferentiation of myelinating oligodendrocytes and subsequent cell proliferation. Journal of Neuroimmunology 1995(Suppl 1): 12
Worobec, A.S.; Semere, T.; Nagata, H.; Metcalfe, D.D. 1997: The C-kit mutation in patients with mastocytosis A follow-up study. Journal of Allergy and Clinical Immunology 99(1 Part 2): S124
Feng, H.L.; Sandlow, J.I.; Sandra, A. 1998: The C-kit receptor and its function in human spermatozoa. Journal of Andrology (Suppl ): 41
Nakata, K.; Miyamoto, S.; Bernier, S.; Tanaka, M.; Utani, A.; Krebsbach, P.; Rhodes, C.; Yamada, Y. 1996: The c-propeptide of type Ii procollagen binds to the enhancer region of the type Ii procollagen gene and regulates its transcription. Annals of the new York Academy of Sciences 785: 307-308
Walther, F.J.; David Cu, R.; Leung, C.; Mehta, E.I.; Waring, A.J.; Gordon, L.M. 1994: The C-terminal GP41 peptide of human immunodeficiency virus lyses alveolar type II lung cells. Pediatric Research 37(4 Part 2): 355A
Sato, C.; Takagi, S.; Tomita, T.; Iwatsubo, T. 2008: The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the gamma-secretase. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 28(24): 6264-6271
Boddeke, H.W.G.M.; Meigel, I.; Boeijinga, P.; Swoboda, R. 1994: The C-terminal amyloid precursor protein fragment His 657-Lys 676 reverses noradrenaline- and enkephalin-induced inhibition of voltage sensitive calcium currents in NG108-15 hybrid cells. Society for Neuroscience Abstracts 20(1-2): 1249
Chaudhuri, A.R.; Luduena, R.F. 1996: The C-terminal domain as a regulator of tubulin conformation Effect of the C-terminal domain on the interaction of tubulin with phomopsin A. Molecular Biology of the Cell 7(Suppl ): 43A
Yang, B.; Zhu, W.G.; Porter, B.; Johnson, L.B.; White, F.F. 1998: The C-terminal domain of AvrXa10 contains an eukaryotic-like acidic transcriptional activation domain and is required for elicitation of resistance. Phytopathology 88(9 Suppl): S101
Xiong, J.; Farmer, C.S.; Kurtz, D.M.Jr 1997: The C-terminal domain of Desulfovibrio vulgaris dcrH gene product is a hemerythrin homolog. FASEB Journal 11(9): A1340
Scheurwater, E.M.; Clarke, A.J. 2008: The C-terminal domain of Escherichia coli YfhD functions as a lytic transglycosylase. Journal of Biological Chemistry 283(13): 8363-8373
Dahmus, M.E.; Chambers, R.S.; Chesnut, J.D.; Dahmus, G.K.; Kang, M.E.; Lee, S.S.; Lehman, A. 1994: The C-terminal domain of RNA polymerase II Involvement in promoter recruitment and release. FASEB Journal 8(7): A1326
Williams, B.Y.; Needleman, D.H.; Grabarek, Z.; Strasburg, G.M.; Hamilton, S.L. 1998: The C-terminal domain of calmodulin modulates the skeletal muscle Ca2+ release channel. Biophysical Journal 74(2 Part 2): A61
Pillot, T.; Lins, L.; Vanloo, B.; Brasseur, R.; Vandekerckhove, J.; Rosseneu, M. 1996: The C-terminal domain of the Alzheimer beta-amyloid protein is a fusion peptide Isoform specific modulation of the fusogenic properties by human apolipoprotein E. Circulation 94(8): I103
Simon, M.; Pavlik, P.; Hartig, A.; Binder, M.; Hamilton, B. 1994: The C-terminal domain of the Sc ADR1 transcription factor is necessary for regulation of peroxisome proliferation by fatty acids. Acta Histochemica et Cytochemica 27(4): 378
Kainz, M.; Gourse, R.L. 1996: The C-terminal domain of the alpha subunit of E coli RNA polymerase is required for efficient Rho-dependent transcription termination. Abstracts of the General Meeting of the American Society for Microbiology 96: 524
D.B.e, I.; Marcinkiewicz, M.; Day, R.; Nakayama, K.; Seidah, N.G. 1995: The C-terminal domain of the pro-protein convertase PC5 is involved in its intracellular routing in AtT-20 cells. Molecular Biology of the Cell 6(Suppl ): 69A
Marín-Villa, M.; Vargas-Inchaustegui, D.A.; Chaves, S.P.; Tempone, A.J.; Dutra, J.M.F.; Soares, M.J.; Ueda-Nakamura, T.; Mendonça, S.C.F.; Rossi-Bergmann, B.; Soong, L.; Traub-Csekö, Y.M. 2008: The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection. Molecular and Biochemical Parasitology 162(1): 52-59
Lopez Ribot, J.L.; Chaffin, W.L. 1997: The C-terminal fragment of entactin contains binding domains for Candida albicans. Abstracts of the General Meeting of the American Society for Microbiology 97: 268
Khairulina, Y.S.; Molotkov, M.V.; Bulygin, K.N.; Graifer, D.M.; Ven'yaminova, A.G.; Karpova, G.G. 2008: The C-terminal fragment of ribosomal protein S15 is located in the decoding site of the human ribosome. Molecular Biology 42(2): 270-276
Fraser, S.P.; Djamgoz, M.B.A.; Chong, Y.H.; Suh, Y.H. 1995: The C-terminal fragment of the Alzheimers disease beta-amyloid precursor protein is a potent inducer of membrane currents in Xenopus oocytes. Journal of Physiology (Cambridge) 489P: 66P
Ono, S.; Yamakita, Y.; Yamashiro, S.; Matsudaira, P.T.; Matsumura, F. 1994: The C-terminal fragments of human fascin contain an actin-binding domain. Molecular Biology of the Cell 5(Suppl ): 398A
Sinn,J.P.; Jensen,P.J.; McNellis,T.W.; Oh,C.S.; Carpenter,S.C.D.; Beer,S.V. 2008: The C-terminal half of Erwinia amylovora HrpN plays an essential role in its secretion, virulence, and hypersensitive response-eliciting activities. Acta Horticulturae 793: 265-270
Sinn, J.P.; Oh, C.-S.; Jensen, P.J.; Carpenter, S.C.D.; Beer, S.V.; McNellis, T.W. 2008: The C-terminal half of the HrpN virulence protein of the fire blight pathogen Erwinia amylovora is essential for its secretion and for its virulence and avirulence activities. Molecular Plant-Microbe Interactions: Mpmi 21(11): 1387-1397
Kimura, E.; Matsuura, I.; Tai, K.; Nakashima, K.I.; Yazawa, M. 1995: The C-terminal half-molecular domain of calmodulin is responsible for high-affinity interaction with target enzymes. Proceedings of the Japan Academy B Physical and Biological Sciences 71(9): 293-298
Ladjimi, M.M.; Benaroudj, N.; Fouchaq, B.; Batelier, G.; Triniolles, F. 1995: The C-terminal peptide binding domain is essential for self-association of the molecular chaperone HSC70. Journal of Cellular Biochemistry Suppl 1995(19B): 198
Janciauskiene, S.; Eriksson, S. 1995: The C-terminal peptide from alpha-1-antitrypsin promotes cholesterol nucleation. Journal of Hepatology 23(Suppl 1): 164
Janciauskiene, S.; Lindgren, S. 1998: The C-terminal peptide of antitrypsin increases LDL binding in HepG2 cells. Journal of Hepatology 28(Suppl 1): 84
Rao, J.; Karande, A.A.; Adiga, P.R. 1998: The C-terminal peptide of chicken riboflavin carrier protein is a minivaccine in rodents for pregnancy curtailment. American Journal of Reproductive Immunology 40(4): 269
Yamamoto, Y.miko; Ohto, Y.ji; Satoh, Kimiyuki 1998: The C-terminal processing of precursor D1 protein in the photosystem II complex in thylakoid membrane. Plant and Cell Physiology 39(Suppl ): S20
Gohda, K.; Oyama, T.; Okada, K. 1998: The C-terminal region of Arabidopsis HY5 is important for proper function. Plant and Cell Physiology 39(Suppl ): S149
Nishizawa, K.M.ruyama, N.U.sumi, S. 2006: The C-terminal region of SaB subunit of soybean SbB-conglycinin contains two types of vacuolar sorting determinants. Plant molecular biology 62(1-2): 111-125
Bova, M.P.; Fung, B.K.K. 1994: The C-terminal region of alpha-A crystallin is involved in its chaperone function. IOVS Investigative Ophthalmology and Visual Science: 35(4)
Jie, Z.; Xu, L.; Yang, F. 2008: The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24. Archives of Virology 153(11): 2103-2106
Boesze Battaglia, K.; Napoli, A.J.; Guo, Y. 1998: The C-terminal region of peripherin/rds promotes membrane adhesion and model membrane fusion. IOVS Investigative Ophthalmology and Visual Science 39(4): S677
Eertmoed, A.L.; Green, W.N. 1996: The C-terminal region of the gamma-subunit is needed for full assembly of the acetylcholine receptor. Society for Neuroscience Abstracts 22(1-3): 1525
Sari, F.; Heinrich, M.; Meyer, W.; Braus, G.H.; Irniger, S. 2008: The C-terminal region of the meiosis-specific protein kinase Ime2 mediates protein instability and is required for normal spore formation in budding yeast. Journal of Molecular Biology 378(1): 31-43
Tomikawa, C.; Ochi, A.; Hori, H. 2008: The C-terminal region of thermophilic tRNA m7 G46 methyltransferase TrmB stabilizes the dimer structure and enhances fidelity of methylation. Proteins Structure Function and Bioinformatics 71(3): 1400-1408
De Mot, R.; Vanderleyden, J. 1994: The C-terminal sequence conservation between OmpA-related outer membrane proteins and MotB suggests a common function in both gram-positive and gram-negative bacteria, possibly in the interaction of these domains with peptidoglycan. Molecular Microbiology 12(2): 333-334
Schroeder, H.; Leventis, R.; Rex, S.; Schelhaas, M.; Nagele, E.; Waldmann, H.; Silvius, J.R. 1997: The C-terminal sequence of mature N-ras is palmitoylated specifically at the plasma membrane in mammalian fibroblasts. Molecular Biology of the Cell 8(Suppl ): 85A
Groot, N.B.; Lookene, A.; Olivercrona, G.; Bruin, J.J.P.K.stelein And Taco 1996: The C-terminal tryptophan cluster in lipoprotein lipase is involved in the binding to lipoproteins. Circulation 94(8): I153
Smertenko, A.P.; Kaloriti, D.; Chang, H.-Y.; Fiserova, J.; Opatrny, Z.; Hussey, P.J. 2008: The C-terminal variable region specifies the dynamic properties of Arabidopsis microtubule-associated protein MAP65 isotypes. Plant Cell 20(12): 3346-3358
Okuda, K.; Van Etten, R.; D'andrea, A.; Griffin, J.D. 1997: The C-terminus of C-ABL is required for proliferation and viability signaling in a c-ABL/EPO receptor fusion protein. Blood 90(10 Suppl 1 Pt 1): 250A
Mechanic, L.E.; Matson, S.W. 1997: The C-terminus of E coli helicase II is essential for DNA binding. FASEB Journal 11(9): A1191
Haney, P.M.; Mueckler, M.M. 1994: The C-terminus of GLUT4 confers insulin-sensitive subcellular targeting. Pediatric Research 37(4 Part 2): 90A
Subramaniam, P.S.; Mujtaba, M.G.; Siler, K.I.; Paddy, M.R.; Johnson, H.M. 1998: The C-terminus of IFNgamma contains a functional nuclear localization sequence. FASEB Journal 12(4): A271
Rarick, H.M.; Solaro, R.J.; Martin, A.F. 1997: The C-terminus of cardiac troponin I is required for full inhibitory activity and Ca-2+-sensitivity of rat myofibrils. Biophysical Journal 72(2 Part 2): A59
Kirchner, J.; Seiler, S.; Aist, J.R.; Schliwa, M. 1998: The C-terminus of fungal conventional kinein Regions important for in vivo function. Molecular Biology of the Cell 9(Suppl ): 31A
Tremblay, J.M.; HelmkampG.M.Jr.; Yarbrough, L.R. 1995: The C-terminus of phosphatidylinositol transfer protein modulates its affinity for phospholipid vesicles. FASEB Journal 9(6): A1308
Ziporen, L.; Park, K.S.; Li, Z.Q.; Sabnekar, P.; Arepally, G.; Cines, D.; Poncz, M. 1997: The C-terminus of platelet factor 4 is required for recognition by heparin-induced thrombocytopenia antibodies. Blood 90(10 Suppl 1 Pt 1): 403A
Seyda, A.; Mceachern, G.; Robinson, B.H. 1997: The C-terminus of the alpha subunit of the E1 component of human pyruvate dehydrogenase complex might regulate the assembly of a stable heterotetramer. American Journal of Human Genetics 61(4 Suppl): A261
Jarrett, J.T.; Berger, E.P.; Lansbury, P.T. 1993: The C-terminus of the beta protein is critical in amyloidogenesis. Annals of the new York Academy of Sciences 695: 144-148
Skiba, N.P.; Artemyev, N.O.; Mills, J.S.; Hamm, H.E. 1994: The C-terminus of the gamma subunit of rod cGMP PDE contains distinct sites of interaction with the enzyme catalytic subunits and transducin alpha. Journal of Cellular Biochemistry Suppl 1994(18B): 307
A.H.sani, H.; Kunamneni, R.K.; Hinck, C.S.; Cushman, S.W. 1998: The C-terminus of the glucose transporter GLUT4 lacks targeting signals but modulates endocytosis. Molecular Biology of the Cell 9(Suppl ): 327A
Eldering, E.; Verpy, E.; Meo, T.; Tosi, M. 1994: The C-terminus of the serpin C1 inhibitor contains crucial residues that prevent spontaneous insertion of the reactive centre loop. Journal of Cellular Biochemistry Suppl 1994(18D): 154
Bagby, G.C.; Kenney, N.; Ratbun, K.; Keeble, W.; Tower, P. 1994: The C-type Fanconi anemia complementing gene encodes a protein that slows the death rate of factor-deprived hematopoietic cells in vitro. Blood 84(10 Suppl 1): 14A
Weis, W.I.; Taylor, M.E.; Drickamer, K. 1998: The C-type lectin superfamily in the immune system. Immunological Reviews 163: 19-34
Habener, J.F.; Vallejo, M.; Ron, D. 1994: The C/EBP family of nuclear transcription on regulatory proteins. Journal of Cellular Biochemistry Suppl 1994(188): 314
Avila, E.L.; Nesathas, S.; Varagona, M.J. 1998: The C1 regulatory protein in maize contains two bipartite NLSs. Plant Biology (Rockville) : 72
Peterson, P.A. 1993: The C1-I allele in maize Its origin via a transposition event. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 44
Liquornik, K.N.; Liacouras, C.A.; Ruchelli, E.D.; Metz, D.C. 1998: The C13-urea breath test An excellent noninvasive method for detection of H pylori infection in pediatric patients. Gastroenterology 114(4 Part 2): A205, Il 15
Steinfath, M.; Singh, S.; Scholz, J.; Wappler, F.; Koechling, A.; Roewer, N.; Schulte, A.E.ch, J. 1994: The C1840-T mutation in the ryanodine receptor gene does not influence the in-vitro contracture response in malignant hyperthermia susceptible patients. Anesthesiology 81(3A): A419
Ghebrehiwet, B.; Lu, P.D.; Zhang, W.; Keilbaugh, S.A.; Leigh, L.E.A.; Eggleton, P.; Reid, K.B.M.; Peerschke, E.I.B. 1997: The C1q-binding membrane proteins, gC1q-R and cC1q-R, associate to form a metal ion-independent complex. Journal of Allergy and Clinical Immunology 99(1 Part 2): S373
Torrejon, M.; Geneviere, A.M.; Hinrichs, M.V.; Olate, J. 1998: The C2 cytosolic loop of adenylyl cyclase interacts with the activated form of Galphas protein. Molecular Biology of the Cell 9(Suppl ): 121A
Stevens, R.T.; Newman, H.M.; Apkarian, A.V. 1994: The C2 nerve innervation extends from lamina I of the trigeminal N caudals to the spinal cervical enlargement. Society for Neuroscience Abstracts 20(1-2): 121
Liu, B.; Sun, D.; Xia, W.; Hung, M.C.; Yu, D. 1997: The C219 anti-p170-mdr-1 monoclonal antibody cross-reacts with p185-c-erbB2 in breast cancer cells Precautions on evaluating p170-mdr-1 in p185-c-erbB2 overexpressing tumors. Proceedings of the American Association for Cancer Research 38: 386
Li, A.; Prasad, A.; Mincemoyer, R.; Satorius, C.; Epstein, N.; Finkel, T.; Quyyumi, A.A. 1998: The C242T polymorphism of the p22hox gene does not decrease the risk of coronary artery disease. Circulation 98(17): I735
Stuart, K.A.; Busfield, F.; Jazwinska, E.C.; Gibson, P.; Butterworth, L.A.; Cooksley, W.G.E.; Powell, L.W.; Crawford, D.H.G. 1997: The C282Y mutation in HFE is common in Australian patients and can act independently of HCV to precipitate porphyria cutanea tarda. Hepatology 26(4 Part 2): 606A
Barrett, S.; Callagy, G.; Ryan, E.; O'keane, J.C.; Macmathuna, P.; Crowe, J. 1998: The C282Y mutation is not a significant cofactor for more severe liver disease in a cohort of Irish hepatitis C patients. Gastroenterology 114(4 Part 2): A1209
Cook, T.J.; Yu, H.; Sinko, P.J. 1996: The C2BBe cell line A stable brush-border expressing Caco-2 clone. Pharmaceutical Research (New York) 13(9 Suppl): S241
Aminova, L.R.; Luo, S.; Bannai, Y.; Ho, M.; Wilson, B.A. 2008: The C3 domain of Pasteurella multocida toxin is the minimal domain responsible for activation of Gq-dependent calcium and mitogenic signaling. Protein Science: a Publication of the Protein Society 17(5): 945-949
Pierrot-Deseilligny, E. 1994: C3-C4 propriospinal system: an example of integration in the motor control and a possible pathway for motor recovery. Revue Neurologique (Paris) 150(5): 327-329
Alstermark, B.; Lundberg, A. 1992: The C3-C4 propriospinal system Target-reaching and food-taking. Jami, L , Pierrot-Deseilligny, E , Zytnicki, D IBRO (International Brain Research Organization) Series; Muscle afferents and spinal control of movement : 327-354
Zhang, L.; Plow, E.F. 1997: The C3bi binding pocket within the alpha subunit of integrin alpha Mbeta2 resides in a narrow region adjacent to bound cation. Blood 90(10 Suppl 1 Pt 1): 436A-437A
Lopez Ribot, J.L.; Martinez, J.P.; Casanova, M.; Chaffin, W.L. 1994: The C3d-receptor and the 58 kDa fibrinogen-binding mannoprotein of C albicans A comparative study. Abstracts of the General Meeting of the American Society for Microbiology 94: 595
Blom, A.M.; Covell, D.G.; Wallqvist, A.; Dahlbäck, B.; Villoutreix, B.O. 1998: The C4b-binding protein-protein S interaction is hydrophobic in nature. Biochimica et Biophysica Acta 1388(1): 181-189
Zahedi, R.; Braun, M.; Wetsel, R.A.; Davis, A.E.IIi 1998: The C5a receptor is expressed by mesangial and proximal tubular epithelial cells. Molecular Immunology 35(6-7): 358
Yang, S.; Luo, H.Y.; Wilson, M.A.; Wead, W.B.; Harris, P.D. 1993: The C5a-induced small arteriolar dilation in rat striated muscle is not mediated by histamine H1 receptors. FASEB Journal 7(3-4): A907
Smythe, H. 1992: The C6-7 syndrome, features and treatment response. Arthritis and Rheumatism 35(9 Suppl): S351
Reuner, K.H.; Ruf, A.; Litfin, F.; Patscheke, H. 1998: The C667fwdarwT mutation in the methylene tetra hydrofolate reductase gene and stroke. Annals of Hematology 76(Suppl 1): A34
Holmes, Z.; Regan, L.; Chilcott, I.; Cohen, H. 1998: The C677T MTHFR mutation is not predictive of risk in women with a history of recurrent miscarriage. British Journal of Haematology 102(1): 250
Dierkes, J.; Ambrosch, A.; Jeckel, A.; Boeing, H.; Luley, C. 1998: The C677T polymorphism of the MTHFR and the plasma homocysteine concentration in a middle-aged population in East Germany. Netherlands Journal of Medicine 52(Suppl ): S5-S6
Wuerzner, R.; Fernie, B.A.; Hobart, M.J.; Orren, A.; Lachmann, P.J. 1993: The C7 M/N polymorphism is determined by a neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15. Molecular Immunology 30(Suppl 1): 63
Cremaschi, A.; Fassini, G.; Motterlini, E.; Piacentini, G.; Valcarenghi, M. 1993: The CA 125 role in planning of therapy in a patient with hidden neoplasia with bony metastases. Anticancer Research 13(5B): 1741
Chandrasekharappa, S.C.; King, S.E.; Freedman, M.L.; Hayes, S.T.; Bowcock, A.M.; Collins, F.S. 1993: The CA repeat marker D17S791 is located within 40 kb of the WNT3 gene on chromosome 17q. Genomics 18(3): 728-729
Yoshimura, S.H.; Zhao, J.; Vasilets, L.A.; Gu, Q.; Ishii, T.; Takeyasu, K.; Schwarz, W. 1998: The CA2+/calmodulin binding domain of the Ca2+-ATPase linked to the Na+/K+-ATPase alters ion-transport stoichiometry. Biophysical Journal 74(2 Part 2): A190
Choy, E.; Chiu, V.; Philips, M.R. 1998: The CAAX motif targets proteins to the endoplasmic reticulum. Molecular Biology of the Cell 9(Suppl ): 458A
Spiers, A.; Saba, H.; Balducci, L.; Moscinski, L.; Richard, J.; Huegel, V.; Daniel, P.; Cosgrove, D. 1995: The CADET regimen in acute myeloid leukemia Results in standard-risk patients. Blood 86(10 Suppl 1): 781A
Durr, A.; Cancel, G.; Stevanin, G.; Duyckaerts, C.; Didierjean, O.; Abbas, N.; Agid, Y.; Brice, A. 1996: The CAG repeat determines the clinical and neuropathologic phenotype in spinocerebellar ataxia 3/Machado-Joseph disease. Neurology 46(2 Suppl): A329-A330
Giovannucci, E.; Stampfer, M.J.; Platz, E.A.; Chan, A.J.; Krithivas, K.; Willett, W.C.; Kawachi, I.; Kantoff, P.W. 1998: The CAG within the androgen receptor gene and its relationship to benign prostatic hyperplasia. Journal of Urology 159(5 Suppl): 102
Frost, P., G.H.; Bond, I. 2008: The CAMPFIRE programme in Zimbabwe Payments for wildlife services. Ecological Economics 65(4): 776-787
Ackrill,R. 2008: The CAP and its reform - half a century of change?. Eurochoices: 2, 13-21
Busby, S.; Kolb, A. 1996: The CAP modulon. Lin, E C C Author, Lynch, A S Author Regulation of gene expression in Escherichia coli : 255-279
Carlotti,B. 2008: The CAP under debate implementation and first impacts of the 2003 CAP reform and the Single Area Payment scheme in selected Member States. Ocl: 2, 88-94
Fried, M.G.; Stickle, D.F. 1995: The CAP-DNA interaction Linkage to cation binding. FASEB Journal 9(6): A1465
Eerens, H.C.; Sliggers, C.J.; Van Den Hout, K.D. 1994: The CAR model The Dutch method to determine city street air quality. Atmospheric Environment Part B Urban Atmosphere 27(4): 389-399
Dicato, M.; Ries, F.; Humbel, R.; Thirkill, C. 1993: The CAR-syndrome in malignant lymphoma. Blood 82(10 Suppl 1): 562A
Hofmann, K.; Bucher, P.; Tschopp, J. 1997: The CARD domain: a new apoptotic signalling motif. Trends in Biochemical Sciences 22(5): 155-156
Kleber, H.K. 1997: The CASA multi-center trial of acupuncture for cocaine dependence. Acupuncture and Electro-Therapeutics Research 22(1): 69
D.W.ck, A.L.; Stadler, B.M.; Muller, U.; Jutel, M.; Urwyler, A.; Vassella, C. 1994: The CAST A new dimension in allergy diagnosis. Journal of Allergy and Clinical Immunology 93(1 Part 2): 271
McCartney,G. 2008: The CAT and the MICE key development considerations for the convention and exhibition industry in Macao. Journal Of Convention and Event Tourism: 4, 293-308
Beard, S.E.; Lee, M.J.; Melick, A.; Gee, P. 1997: The CAT-Tox assay Detection of Ames-negative carcinogens. Environmental and Molecular Mutagenesis 29(Suppl 28): 4
Thiemann, G.; Di Marzo, V.; Molleman, A.; Hasenöhrl, R.üd.U. 2008: The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus. Pharmacology Biochemistry and Behavior 89(3): 384-391
Palazuelos, J.; Davoust, N.; Julien, B.; Hatterer, E.; Aguado, T.; Mechoulam, R.; Benito, C.; Romero, J.; Silva, A.; Guzman, M.; Nataf, S.; Galve-Roperh, I. 2008: The CB2 cannabinoid receptor controls myeloid progenitor trafficking. Journal of Biological Chemistry 283(19): 13320-13329
Woodland, R.T.; Schmidt, M.R.; Korsmeyer, S.; Gravel, K.A. 1995: The CBA/N X-linked immunodeficiency reduces B cell survival and endogenous BCL-2. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 276
Inoue, T.; Nakamura, H.; Takano, K.; Ono, H. 1996: The CBF and Lambda values in the brain tissue around an infarction. Acta Neurologica Scandinavica 93(Suppl 166): 146
Oyama, H.; Niwa, M.; Kida, Y.; Tanaka, T.; Iwakoshi, T.; Kitamura, R.; Kobayashi, T. 1996: The CBF distribution in Xenon-CT CBF study. Acta Neurologica Scandinavica. Supplementum 166: 144-145
Pereira, Dirce Maria Carraro; Pereira, Gonalo Amarante Guimaraes; El Dorry, Hamza 1997: The CBH1 promoter from Trichoderma reesei is controlled by a glucose repression pathway of Saccharomyces cerevisiae. FASEB Journal 11(9): A1383
Lewin, A.S.; Shaw, L.C.; Tirupati, H.K. 1995: The CBP2 protein promotes the folding of a group 1 intron during transcription. Journal of Cellular Biochemistry Suppl 1995(19A): 211
Seve, A.P.; Felin, M.; Hadj Sahraoui, Y.; Doyennette Moyne, M.A.; Aubery, M.; Hubert, J. 1994: The CBP35-CBP70 interaction is modulated by the binding of lactose to CBP35 in HL60 cell nuclei. Journal of Cellular Biochemistry Suppl 1994(18D): 281
Poli, G.; Alfano, M.; Mengozzi, M.; Lazzarin, A.; Mantovani, A.; Vicenzi, E. 1997: The CC chemokine MCP-1 induces HIV replication in in vivo infected PBMC. Cytokine 9(11): 893
Chen, B.; Xue, Y.Y.; Burdick, M.D.; Kunkel, S.L.; Strieter, R.M. 1997: The CC chemokines RANTES, MCP-1 and MIP-1-alpha are expressed and MIP-1-beta is suppressed during lung allograft rejection. Journal of Investigative Medicine 45(7): 349A
Couturier, M.F.; Bernard, P.; Van Melderen, L.; Salmon, M.; El Bahassi, M.; Pato, M.; Kezdy, K.; Higgins, P. 1995: The CCD killer system of plasmid. Journal of Cellular Biochemistry Suppl 1995(19A): 102
Pawley, J.; Blouke, M.; Janesick, J. 1998: The CCDiode photodetector for light from small sources. Scanning 20(3): 146-147
Pisegna, J.R.; Lew, E.; Tarasova, N.I.; Walsh, J.H.; Wank, S.A. 1998: The CCK B receptor in the human kidney mediates gastrin-stimulated urinary sodium excretion. Digestive Diseases and Sciences 43(8): 1865
Kedzie, K.A.; Renner, K.J. 1993: The CCK antagonist, lorglumide , does not alter dopamine levels in rat caudate as measured by microdialysis. Society for Neuroscience Abstracts 19(1-3): 1383
Wang, L.; Lloyd, K.C.K.; Martinez, V.; Tache, Y. 1997: The CCK-A antagonist devazepide selectively blocks intraduodenal loading with D-glucose-induced neuronal activation in the rat brain. Gastroenterology 112(4 Suppl): A1198
Santucci, V.; Gueudet, C.; Thurneyssen, O.; Gully, D.; Soubrie, P.; Le Fur, G. 1994: The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat. Annals of the new York Academy of Sciences 713: 364-367
Ruiz Gayo, M.; Hernando, F.; Fuentes, J.A. 1994: The CCK-A receptor antagonist devazepide decreases retention of immobility by a glucocorticoid related mechanism in the forced-swim test in rats. Society for Neuroscience Abstracts 20(1-2): 1362
Landi, M.; Croci, T.; Gully, D.; Le Fur, G.; Maffrand, J.P.; Manara, L. 1996: The CCK-A-antagonist SR 27897B partially restores rat gastric emptying delayed by intraduodenally fed fats. Gastroenterology 110(4 Suppl): A701
Xu, X.J.; Hokfelt, T.; Hughes, J.; Wiesenfeld Hallin, Z. 1994: The CCK-B antagonist C1988 enhances the analgesic effect of morphine in rats with neuropathic pain. Neuropeptides 26(Suppl 1): 34
Rasmussen, K.; Helton, D.R.; Berger, J.E.; Scearce, E. 1994: The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response. Annals of the new York Academy of Sciences 713: 374-376
Rasmussen, K.; Mcquaid, L.A.; Stockton, M.E. 1993: The CCK-B antagonist LY288513 blocks some behavioral effects of MK-801 and phencyclidine. Society for Neuroscience Abstracts 19(1-3): 172
Kayser, V.; Idanpaan Heikkila, J.J.; Rivot, J.P.; Guilbaud, G. 1997: The CCK-B receptor antagonist, L-365,260, prevents morphine tolerance and dependence in mononeuropathic rats. Society for Neuroscience Abstracts 23(1-2): 1537
Tattersall, F.D.; Jackson, A.; Bentley, G.; Tricklebank, M.D. 1992: The CCK-B receptor antagonist, L-365260 does not substitute for cocaine or morphine in rat models of drug abuse. Society for Neuroscience Abstracts 18(1-2): 899
D.W.erth, A.; Von Schrenck, T.; Schulz, M.; Wolf, G.; Schroeder, S.; Wall, S.; Greten, H. 1995: The CCK-B receptor in kidney Evidence of receptor expression in tubular and mesangial cell lines. Gastroenterology 108(4 Suppl): A962
Fossa, A.A.; Depasquale, M.J.; Morrone, J.; Zorn, S.H.; Lowe, J.H.; Mclean, S. 1995: The CCK-B receptor mediates the cardiovascular effects of cholecystokinin-tetrapeptide in guinea pigs and dogs. FASEB Journal 9(4): A900
Kopin, A.S.; Beinborn, M.; Lee, Y.M.; McBride, E.W.; Quinn, S.M. 1994: The CCK-B/gastrin receptor. Identification of amino acids that determine nonpeptide antagonist affinity. Annals of the new York Academy of Sciences 713: 67-78
Norlen, P.; Ding, X.; Bjorkqvist, M.; Hakanson, R. 1998: The CCK-B/gastrin receptor antagonist YM022 causes oxyntic mucosal atrophy and deactivates ECL cells in the rat stomach. Gastroenterology 114(4 Part 2): A1169
Caplin, M.E.; Michaeli, D.; More, L.; Pounder, R.E.; Dhillon, A.P. 1996: The CCK-B/gastrin receptor in hepatocellular carcinoma. Gastroenterology 110(4 Suppl): A1162
Böhlig, L.; Metzger, R.; Rother, K.; Till, H.; Engeland, K. 2008: The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor. Cell Cycle 7(9): 1254-1261
Lachaux, B.; Benard, F.; Davidian, S.; Aulagner, G.; Fondarai 1997: The CCPPRB The risk of references and notice disparity. European Psychiatry 12(Suppl 2): 181S
Benz, C.; Sauer, P.; Kloeters Plachky, P.; Stremmel, W.; Stiehl, A. 1998: The CD 95 receptor/ligand system does not trigger bile acid-induced apoptosis in primary human hepatocytes. Gastroenterology 114(4 Part 2): A1211
Delmotte, J.S. 1998: The CD-ROM. Acta Endoscopica 28(5): 599
Gilman, E.F.; Beck, H. 1997: The CD-ROM-World wide Web hybrid. HortScience 32(3): 553
Acland, G.M.; Aguirre, G.D. 1996: The CD/CD PRCD/PRCD double mutant dog Expression of a rod-cone degeneration in a cone-free retina. IOVS Investigative Ophthalmology and Visual Science 37(3): S502
Porcelli, S.A.; Segelke, B.W.; Sugita, M.; Wilson, I.A.; Brenner, M.B. 1998: The CD1 family of lipid antigen-presenting molecules. Immunology Today 19(8): 362-368
Moody, D.B.; Sugita, M.; Peters, P.J.; Brenner, M.B.; Porcelli, S.A. 1996: The CD1-restricted T-cell response to mycobacteria. Research in Immunology 147(8-9): 550-559
Cao, J.; Vescio, R.A.; Kim, A.; Hong, C.H.; Lee, C.; Lichtenstein, A.K.; Berenson, J.R. 1994: The CD10 antigen is expressed on a subpopulation of malignant cells in all patients with multiple myeloma. Blood 84(10 Suppl 1): 171A
Delikat, S.; Zuzel, M.; Galvani, D.W. 1994: The CD10 of bone marrow stromal cells can downmodulate the effects of IL1-beta. British Journal of Haematology 86(Suppl 1): 60
Ingalls, R.R.; Arnaout, M.A.; Delude, R.L.; Flaherty, S.; Savedra, R.; Golenbock, D.T. 1998: The CD11/CD18 integrins: characterization of three novel LPS signaling receptors. Progress in Clinical and Biological Research 397: 107-117
Grunvald, E.L.; Hickstein, D.D. 1993: The CD11b/CD18 leukocyte integrin mediates cellcell adherence of transfected K562 leukemia cells. Clinical Research 41(1): 20A
Fingerle, G.; Stroebel, M.; Pforte, A.; Ziegler Heitbrock, H.W.L. 1993: The CD14+/CD16+ blood monocytes subpopulation exhibits features of tissue macrophages. Immunobiology 189(1-2): 40
Gangloff, S.C.; Seydel, U.; Goyert, S.M. 1997: The CD14-independent response to LPS involves a low affinity receptor that is influenced by LPS chain length. FASEB Journal 11(9): A1439
Weninger, W.; Mildner, M.; Mayer, C.; Rendl, M.; Ban, J.; Geusau, A.; Tanew, A.; Majdic, O.; Tschachler, E. 1998: The CD146 antigen is induced on suprabasal keratinocytes during inflammation, but is downregulated on malignant keratinocytes. Journal of Dermatological Science 16(Suppl 1): S78
Rosmarin, A.G.; Caprio, D.; Trampe, G.; Levy, R. 1993: The CD18 promoter directs leukocyte-specific, myeloid-inducible expression. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 171
Lankester, A.C.; Van Noesel, C.J.M.; Van Schijndel, G.M.W.; Van Lier, R.A.W. 1993: The CD19 complex on human B cells contains the SRC-family kinase lyn and has characteristics of a signaling module. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 254
Tedder, T.F.; Inaoki, M.; Sato, S. 1997: The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6(2): 107-118
Fearon, D.T. 1993: The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. Current Opinion in Immunology 5(3): 341-348
Tedder, T.F.; Zhou, L.J.; Engel, P. 1994: The CD19/CD21 signal transduction complex of B lymphocytes. Immunology Today 15(9): 437-442
Mooney, N.; Zilber, M.T.; Charron, D.; Gelin, C. 1996: The CD1A molecule participates in superantigen-induced activation of human thymocytes via tyrosine phosphorylation. Tissue Antigens 48(4-2): 472
Thevenin, C.; Wilson, G.L.; Kehrl, J.H. 1994: The CD20 gene is an excellent prototype for the study of B lineage specific gene expression. Clinical Research 42(2): 123A
Thevenin, C.; Wilson, G.L.; Kehrl, J.H. 1994: The CD20 promoter as a prototype for the study of B lineage specific genes. FASEB Journal 8(4-5): A788
Pawliuk, R.; Kay, R.; Lansdorp, P.; Hough, M.; Humphries, K. 1993: The CD24 cell surface antigen as a dominant selectable marker in retroviral mediated gene transfer. Journal of Cellular Biochemistry Suppl 1993(17 Part E): 203
June, C.H.; Vandenberghe, P.; Thompson, C.B. 1994: The CD28 and CTLA-4 receptor family. Chemical Immunology 59: 62-90
Mazzaccaro, R.J. 1993: The CD28 receptor Its role in T-cell activation and anergy, and prospect for therapeutic applications. Einstein Quarterly Journal of Biology and Medicine 11(2): 53-59
Blumcke, I.; Giencke, K.; Wardelmann, E.; Wolf, H.K.; Schramm, J.; Elger, C.E.; Wiestler, O.D. 1998: The CD34 epitope is expressed in neoplastic lesions associated with chronic temporal lobe epilepsies. Epilepsia 39(Suppl 6): 218
Hassan, H.T.; Schleimer, B.; Krog, C.; Stockschlaeder, M.; Krueger, W.; Zander, A.R. 1996: The CD34 positive cells percentage in bone marrow of healthy donors determines the progenitor cells yield in the BM harvest and the hematological recovery after allogeneic transplantation. Annals of Hematology 73(Suppl 2): A41
Bonnet, D.; Dick, J.E. 1996: The CD34++ CD38- stem cell subfraction is responsible for the initiation of human acute myeloid leukemia in NOD-SCID mice. Experimental Hematology 24(9): 1126
Waller, E.K.; Olweus, J.; Lund Johansen, F.; Huang, S.; Nguyen, M.; Guo, G.R.; Terstappen, L. 1994: The CD34+, CD38-, HLADR- fraction of human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 84(10 Suppl 1): 417A
Shubinsky, G.; Schlesinger, M. 1997: The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity 7(3): 315-324
Mannie, M.D.; White, G. 1994: The CD4 coreceptor mediates efficacy of T cell antigen receptor interactions with autologous myelin basic protein. Society for Neuroscience Abstracts 20(1-2): 952
Mccready, P.M.; Hansen, R.K.; Burke, S.L.; Sands, J.F. 1994: The CD4 gene transcription regulation is affected by sequences within a 25 kb region flanking the promoter. Abstracts of the General Meeting of the American Society for Microbiology 94: 251
Mrc Anrs Coordinating Committee For The European Australian Alpha Trial 1993: The CD4 response to ddI A comparison with mortality in ALPHA patients. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 79
Diepolder, H.; Gerlach, T.; Zachoval, R.; Hoffmann, R.; Jung, M.C.; Wierenga, E.; Scholz, S.; Houghton, M.; Pape, G. 1996: The CD4+ T lymphocyte response to the non-structural protein 3 , which is associated with virus elimination in acute hepatitis C, focuses on a single, promiscuous 14-amino-acid peptide. Hepatology 24(4 Part 2): 373A
Korsgren, O.; Wallgren, A.; Ridderstad, A.; Satake, M.; Möller, E.; Karlsson-Parra, A. 1995: The CD4+ effector cell in islet xenotransplantation is a macrophage and not a T-lymphocyte. Transplantation Proceedings 27(1): 251
Soumelis, V.; Rissoan, M.C.; Grouard, G.; Durand, I.; Liu, Y.J. 1997: The CD4+CD11C- dendritic cell precursor Inhibition by interleukin 4 and arguments for a lymphoid DC differentiation pathway in human. Experimental Hematology 25(8): 734
Ma, Y.e; Visser, Lydia; Blokzijl, Tjasso; Harms, Geert; Atayar, Cigdem; Poppema, Sibrand; Van-Den-Berg, Anke 2008: The CD4+CD26-T-cell population in classical Hodgkins lymphoma displays a distinctive regulatory T-cell profile. Laboratory Investigation 88(5): 482-490
Yelon, D.L.; Berg, L.J. 1994: The CD4-class II MHC interaction What is the role of co-receptor during positive selection?. Journal of Cellular Biochemistry Suppl 1994(18D): 460
Kotowicz, K.; Herbert, J.; Klein, N.; Smith, S.; Callard, R. 1996: The CD40 antibody panel can distinguish phenotypically and functionally between B cells, monocytes and endothelial cells. Tissue Antigens 48(4-2): 380
Pammer, J.; Plettenberg, A.; Weninger, W.; Diller, B.; Mildner, M.; Uthman, A.; Tschachler, E. 1995: The CD40 antigen is expressed by vascular endothelial cells and tumor cells in Kaposis sarcoma. Journal of Investigative Dermatology 104(4): 666
Larsen, C.P.; Pearson, T.C. 1997: The CD40 pathway in allograft rejection, acceptance, and tolerance. Current Opinion in Immunology 9(5): 641-647
Miura, Y.; Lipsky, P.E. 1997: The CD40 response element in the human germline epsilon promoter involves in NFkappaB binding site. Arthritis and Rheumatism 40(9 Suppl): S177
Grewal, I.S.; Borrow, P.; Pamer, E.G.; Oldstone, M.B.; Flavell, R.A. 1997: The CD40-CD154 system in anti-infective host defense. Current Opinion in Immunology 9(4): 491-497
Kweon, M.; Mcghee, J.R.; Yamamoto, M.; Maliszewski, C.R.; Wakatsuki, Y.; Kiyono, H.; Fujihashi, K. 1998: The CD40-CD40L signal pathway is essential for mucosally-induced tolerance. FASEB Journal 12(4): A599
Donners, M.M.P.C.; Beckers, L.; Lievens, D.; Munnix, I.; Heemskerk, J.; Janssen, B.J.; Wijnands, E.; Cleutjens, J.; Zernecke, A.; Weber, C.; Ahonen, C.L.; Benbow, U.; Newby, A.C.; Noelle, R.J.; Daemen, M.J.A.P.; Lutgens, E. 2008: The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 111(9): 4596-4604
Ford, G.S.; Covey, L.R. 1998: The CD40L gene is regulated at the level of mRNA stability. FASEB Journal 12(5): A940
Lopez, J.A.; Li, C.Q.; Chambers, M.; Weisman, S. 1993: The CD42 antibody SZ1, which blocks a site on the GP Ib-IX complex recognized by drug-dependent antibodies, binds to a conformation-dependent epitope on GP IX. Tissue Antigens 42(4): 419
Tanabe, K.K.; Saya, H. 1994: The CD44 adhesion molecule and metastasis. Critical Reviews in Oncogenesis 5(2-3): 201-212
Sleeman, J.; Vallon, R.; Koenig, H.; Sherman, L.; Ponta, H.; Herrlich, P. 1995: The CD44 family of cell surface proteins in normal development and in metastatic cancer. Calcified Tissue International 56(5): 507
Moffat, F.L.; Han, T.; Spalding, P.B.; Peck, M.D.; Jy, W.; Chu, A.; Ahn, Y.S.; Bourguignon, L.Y.W. 1995: The CD44 ligand hyaluronic acid enhances human neutrophil bacterial phagocytosis. FASEB Journal 9(4): A633
Alexander, D.R.; Biffen, M. 1994: The CD45 phosphatase regulates kinase-mediated tyrosine phosphorylation of T-cell antigen receptor components. Journal of Cellular Biochemistry Suppl 1994(18D): 394
Alexander, D.; Goff, L.; Biffen, M.; Shivnan, E.; Shiroo, M. 1993: The CD45 tyrosine phosphatase activates the p59-fyn tyrosine kinase in HPB-ALL T cells. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 307
Wagner, N.; Engel, P.; Tedder, T.F. 1993: The CD45 tyrosine phosphatase downregulates homotypic adhesion in human lymphocytes. Journal of Immunology 150(8 Part 2): 254A
Cifuentes, M.E.; Mittler, R.S.; Rosoff, P.M. 1994: The CD45 tyrosine protein kinase is not required for signaling and activation of human T lymphocytes by the pertussis toxin receptor. Blood 84(10 Suppl 1): 285A
Devaux, P.; Buchholz, C.J.; Schneider, U.; Escoffier, C.; Cattaneo, R.; Gerlier, D. 1997: The CD46 SCR III-IV domains enhance the binding of measles virus but impair the binding of soluble hemagglutinin. Experimental and Clinical Immunogenetics 14(1): 46
Lee, S.M.; Ahn, Y.; Kim, H.T.; Uh, S.; Kim, Y.H.; Park, C.S. 1994: The CD5+ B lymphocyte in the bronchoalveolar lavage fluid of the patients with bronchial asthma. Journal of Allergy and Clinical Immunology 93(1 Part 2): 197
Tarakhovsky, A.; Mueller, W.; Rajewsky, K. 1993: The CD5/Ly-1 deficient homozygous mice. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 206
Fehniger, T.A.; Carson, W.E.; Caligiuri, M.A. 1997: The CD56-bright human NK cell subset is the most potent NK producer of macrophage activating factors. Proceedings of the American Association for Cancer Research 38: 32
Deckert, M.; Breittmeyer, J.P.; Ticchioni, M.; Aussel, C.; Bernard, A. 1993: The CD59 activation pathway induces similar activation events that the TCR/CD3 pathway. Journal of Immunology 150(8 Part 2): 106A
Singer, N.G.; Richardson, B.C.; Sanders, J.; Lialios, F.; Hooper, F.; Powers, D.; Hemati, N.; Bott, C.M.; Fox, D.A. 1994: The CD6 T lymphocyte surface glycoprotein Functional evidence for multiple ligands. Arthritis and Rheumatism 37(9 Suppl): S376
Bruemmer, J.; Ganzer, S.; Ebrahimnejad, A.; Flayeh, R.; Streichert, T.; Wagener, C. 1996: The CD66 complex Activation of tyrosine kinases of the SRC family. Tissue Antigens 48(4-2): 427
Stocks, S.C.; Singer, B.; Dransfield, I.; Grunert, F. 1996: The CD66 complex in regulation of neutrophil effector function. Immunology 89(Suppl 1): 44
Testi, R.; D'Ambrosio, D.; De Maria, R.; Santoni, A. 1994: The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunology Today 15(10): 479-483
Seaman, M.S.; Lemonnier, F.; Forman, J. 1998: The CD8 response to Listeria monocytogenes in mice lacking MHC class Ia molecules. FASEB Journal 12(5): A1087
Cole, G.A.; Hogg, T.L.; Woodland, D.L. 1995: The CD8+ T-cell response to the immunodominant Sendai virus NP-324-332/K-b epitope is extremely diverse in terms of TCR repertoire and fine specificity. Journal of Cellular Biochemistry Suppl 1995(19A): 295
Stranford, S.; Skurnick, J.; Louria, D.; Osmond, D.; Chang, S.Y.; Sninsky, J.; Ferrari, G.; Weinhold, K.; Lindquist, C.; Levy, J. 1998: The CD8+ cell non-cytotoxic, anti-HIV response is associated with protection in HIV-exposed, uninfected individuals. FASEB Journal 12(4): A295
Mollet, L.; Othman, T.B.; Sadat Sowti, B.; Gorochov, G.; Binet, J.L.; Autran, B.; Leblond, V. 1994: The CD8+CD57+ subset in BMT An end-state activation of cytotoxic T-cells during allogeneic BMT-related complications. Blood 84(10 Suppl 1): 729A
Barker, E.; Levy, J. 1998: The CD86 and not the CD80 molecule is responsible for the ability of macrophages to increase the ability of CD8+ cells to suppress HIV replication in CD4+ cells. FASEB Journal 12(4): A295
Hardie, D.L.; Hill, D.; Casamayor, M.; Maclennan, I.C.M. 1996: The CD86 panel. Tissue Antigens 48(4-2): 381
Palmieri, G.; Carretero, M.; Tullio, V.; Perez Villar, J.J.; Lopez Botet, M.; Santoni, A. 1997: The CD94/NKG2-A NK inhibitory complex recruits SHP-1 and SHP-2 tyrosine phosphatases. Natural Immunity 15(4): 191, 1996-
Perez Villar, J.J.; Melero, I.; Navarro, F.; Carretero, M.; Bellon, T.; Llano, M.; Colonna, M.; Geraghty, D.; Lopez Botet, M. 1997: The CD94/NKG2-A inhibitory receptor complex is involved in NK cell-mediated recognition of cells expressing HLA-G1. Natural Immunity 15(4): 176, 1996-
López-Botet, M.; Carretero, M.; Bellón, T.; Pérez-Villar, J.J.; Llano, M.; Navarro, F. 1997: The CD94/NKG2C-type lectin receptor complex in recognition of HLA class i molecules. Research in Immunology 148(3): 155-159
Krammer, P.H. 1997: The CD95 -mediated death-signal and diseases. Journal of Molecular Medicine 75(7): B238
Mueller, M.; Wilder, S.; Israeli, D.; Friedman, S.L.; Galle, P.R.; Oren, M.; Stremmel, W.; Krammer, P.H. 1998: The CD95 gene is a DNA-damage-inducible p53 regulated death receptor gene. Hepatology 28(4 Part 2): 167A
D.M.ria, R.; Boivirant, M.; Cifone, M.G.; Roncaioli, P.; Pallone, F.; Santoni, A.; Testi, R. 1995: The CD95 is constitutively expressed and functional on human lamina propria T lymphocytes A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 750
Debatin, K.M. 1996: The CD95 system in lymphohemopoietic disorders. British Journal of Haematology 93(Suppl 2): 305
Gentry, E.M.; Wooten, K.G. 1993: The CDC National AIDS Hotline A profile of callers and their concerns. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 948
Soule, B.M. 1996: The CDC and HICPAC guideline for isolation precautions in hospitals: commentaries on an evolutionary process. American Journal of Infection Control 24(3): 199-200
Zippel, R.; Martegani, E.; Vanonii, M.; Sturani, E. 1994: The CDC25Mm products corresponding to form I and IV exhibit a different serum-dependent Ras activation. Journal of Cellular Biochemistry Suppl 1994(18B): 271
Castronova, V.; Pintiaux, A.; Lambert, C.; Delhez, B.; Guirguis, R.; Dubois, M.; Holland, S. 1994: The CDI Cyto-Shuttle An original, quick, easy and effective method to perform endometrial wash cytologic screening. American Journal of Clinical Pathology 101(3): 383
Satterwhite, D.J.; Beauchamp, R.D.; Nigro, J.M.; Aakre, M.E.; Moses, H.L. 1996: The CDK inhibitors p27-Kipl, p21-Waf1, p15-MTS2, p18 and p19 Differential regulation of expression during G-1 and response to TGF-beta-1. Journal of Investigative Medicine 44(1): 145A
Makela, T.P.; Weinberg, R.A. 1995: The CDK-activating kinase CAK contains a novel cyclin and is regulated during the G0/G1 transition. Journal of Cellular Biochemistry Suppl 1995(19A): 70
Hong, S.C.; Yoon, S.T.; Janeway, C.A.Jr 1994: The CDR domains of the T cell receptor beta chain affect the fine specificity of MHC recognition. Journal of Cellular Biochemistry Suppl 1994(18D): 341
Chang, B.; Casali, P. 1994: The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunology Today 15(8): 367-373
Kunkel, L.A.; Vescio, R.; Cao, J.; Schiller, G.J.; Lichtenstein, A.K.; Berenson, J.R. 1993: The CDR3 regions of multiple myeloma patients reveal characteristics seen in fetal lymphoid development. Blood 82(10 Suppl 1): 259A
Mauchamp, A.; Aldaz, I. 1997: The CDRS herbarium, an old new research tool for Galapagos. Noticias de Galapagos 1997(58): 27-28
Taylor, J.; Levy, T.; Traber, P.G. 1996: The CDX2 transcription factor appears to require a tissue-specific co-activator to induce transcription from enhancer elements. Gastroenterology 110(4 Suppl): A366
Stanners, C.P.; Rojas, M.; Zhou, H.; Fuks, A.; Beauchemin, N. 1992: The CEA family: a system in transitional evolution?. International Journal of Biological Markers 7(3): 137-142
Thompson, J. 1996: The CEA gene family Only tumour markers or also tumour modulators?. Tumor Biology 17(Suppl 1): 1
Muenzner, P.; Bachmann, V.; Kuespert, K.; Hauck, C.R. 2008: The CEACAM1 transmembrane domain, but not the cytoplasmic domain, directs internalization of human pathogens via membrane microdomains. Cellular Microbiology 10(5): 1074-1092
Rutherford, R.B. 1997: The CEAP classification system and assessing outcome. Vascular Surgery 31(3): 221-222
Boyce, J.R.; May, R.; Ortiz, W. 1995: The CEBAF phased accelerator readiness review A model study. Health Physics 68(6 Suppl): S78
Mcbain, D.C.; Chenier, R.; Fortin, C.; Moore, D.R.J. 1994: The CEPA priority substances assessment program. Canadian Technical Report of Fisheries and Aquatic Sciences 1994(1989): 258
Mayer, J.H.; Mitchell, T.R.; Oliver, S. 1996: The CFC-free formulation of inhaled nedocromil sodium is well tolerated in mild asthmatic patients. European Respiratory Journal Suppl 9(23): 257S
Seidler, U.; Guba, M.; Walter, M.; Gregor, M. 1998: The CFTR anion channel is the predominant transport pathway for HCO3- in agonist-stimulated secretion in rat duodenum. Gastroenterology 114(4 Part 2): A281
Welsh, M.J.; Anderson, M.P.; Rich, D.P.; Berger, H.A.; Sheppard, D.N. 1994: The CFTR chloride channel. Guggino, W B Current Topics in Membranes; Chloride channels 153-171
Machen, T.E.; Fischer, H. 1994: The CFTR displays three distinct functional responses to stimulation. FASEB Journal 8(4-5): A341
Mickle, J.; MacekM.Jr; Egan, M.; Fulmer Smentek, S.; Schwiebert, E.; Guggino, W.; Moss, R.; Cutting, G.R. 1996: The CFTR genotype del14a/S1455X is associated with elevated sweat chloride concentrations in the absence of lung or pancreatic disease. American Journal of Human Genetics 59(4 Suppl): A272
Fischer, H.; Illek, B.; Machen, T.E. 1995: The CFTR is regulated by three functionally distinct phosphatases. Biophysical Journal 68(2 Part 2): A241
Fagan, L.; Dunlop, J.; Carey, N.; Johnson, K.; Payne, S.J. 1996: The CFTR mutation 1154insTC is more common than previously reported. European Journal of Human Genetics 4(Suppl 1): 78
Depagter, C.C.; Penny, L.A. 1995: The CFTR mutation 1811+16kbA-G found in Spanish cystic fibrosis chromosomes is present in North American Hispanics. American Journal of Human Genetics 57(4 Suppl): A330
Foord, S.M.; Mclatchie, L.M.; Fraser, N.J.; Wise, A.; Brown, J.; Main, M.; Thompson, N.; Solari, R.; Lee, M.G. 1998: The CGR1P receptor requires a single transmembrane protein for functional expression. British Journal of Pharmacology 123(Proceedings Suppl ): 365P
Nguyen, M.B.; Pisarri, T.E. 1998: The CGRP receptor antagonist CGRP 8-37 reduces bronchial vasodilation evoked by hypertonic saline in the intrathoracic airways of dogs. FASEB Journal 12(5): A990
Nishio, M.; Umezawa, Y.; Hirota, M.; Takeuchi, Y. 1995: The CH/pi interaction Significance in molecular recognition. Tetrahedron 51(32): 8665-8701
Abramson, J.H.; Gofin, J.; Hopp, C.; Schein, M.H.; Naveh, P. 1994: The CHAD program for the control of cardiovascular risk factors in a Jerusalem community: a 24-year retrospect. Israel Journal of Medical Sciences 30(1): 108-119
Zhang, H.; Rider, S.D.; Henderson, J.T.; Fountain, M.; Chuang, K.; Kandachar, V.; Simons, A.; Edenberg, H.J.; Romero-Severson, J.; Muir, W.M.; Ogas, J. 2008: The CHD3 remodeler PICKLE promotes trimethylation of histone H3 lysine 27. Journal of Biological Chemistry 283(33): 22637-22648
Reinhardt, C.A.; Frey, D.M.; Schein, C.H. 1995: The CHEN cell culture assay for neurotoxicology screening. Experientia 51(ABSTR ): A44
Cooper, P. 1992: The CHIC project. Noothoven van Goor, J, Christensen, J P Studies in Health Technology and Informatics; Advances in medical informatics: Results of the AIM Exploratory Action: 77-87
Corwin, M.; Colton, T.; Neuman, M.; Baird, T.; Brooks, L.; Crowell, D.; Tinsley, L.; Hoppenbrouwers, T.; Keens, T.; Davidson Ward, S.; Ramanathan, R.; Hunt, C.; Hufford, D.; Lister, G.; Weese Mayer, D.; Silvestri, J.; Willinger, M. 1994: The CHIME pilot study. Pediatric Research 37(4 Part 2): 389A
Gooden, D.S. 1996: The CHP as an expert in legal processes. Health Physics 70(6 Suppl): S50
Schlaepfer, I.R.; Hoft, N.R.; Collins, A.C.; Corley, R.P.; Hewitt, J.K.; Hopfer, C.J.; Lessem, J.M.; McQueen, M.B.; Rhee, S.H.; Ehringer, M.A. 2008: The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biological Psychiatry 63(11): 1039-1046
Gillison, A.N. 1996: The CIFOR program in Asia. Bulletin of the Ecological Society of America 77(3 Suppl Part 2): 164
Raimondi, M. 1997: The CIM RAC/ERS in the framework of the Mediterranean Action Plan. Spiteri, A Remote sensing '96 Integrated applications for risk assessment and disaster prevention for the Mediterranean: 69-71
Coccetti, P.; Tripodi, F.; Tedeschi, G.; Nonnis, S.; Marin, O.; Fantinato, S.; Cirulli, C.; Vanoni, M.; Alberghina, L. 2008: The CK2 phosphorylation of catalytic domain of Cdc34 modulates its activity at the G1 to S transition in Saccharomyces cerevisiae. Cell Cycle 7(10): 1391-1401
Krieger, O.; Kasparu, H.; Girschikofsky, M.; Oppitz, P.; Bettelheim, P.; Lutz, D. 1997: The CLAEG-protocol An effective treatment for high risk myeloid leukemias. Blood 90(10 Suppl 1 Pt 2): 244B
Smith, A.M.; Philp, N.H.; Browning, A.J.F. 1992: The CLAM operation and pregnancy. Journal of Obstetrics and Gynaecology 12(5): 310
Pfenning, M.; Palfay, G.; Guillet, T. 2008: The CLEARFIELD R technology - A new broad-spectrum post-emergence weed control system for European sunflower growers. Journal of Plant Diseases and Protection (Sp. Iss. 21): 649-653
Bin Xue; Ge Yu; Wang Sumin 2002: The CLSDB Chinese Lake Status Database and its role in the research of palaeoclimate in East Asia. Daiyonki-Kenkyu = Quaternary Research 41(1): 53-61
Donovan, J.L.; Brookes, S.T.; Kennedy, L.G.; Abrams, P.; Peters, T.J.; Neal, D.E. 1998: The CLasP randomised controlled trial Comparing laser therapy, conservative management and TURP for men with lower urinary tract symptoms. Journal of Urology 159(5 Suppl): 248
Muehlenhoff, M.; Frosch, M.; Hansen, A.; Schahn, R.G.rardy 1992: The CMP-NeuAc Poly-alpha-2,8-sialosylsialyltransferase of Escherichia coli K1 and Neisseria meningitidis group B An approach to determine the catalytically active domains of the enzymes. Biological Chemistry Hoppe-Seyler 373(9): 803-804
Clark, G.J.; Green, B.J.; Hart, D.N.J. 1997: The CMRF-35 molecules are differentially expressed in haemopoietic cells. Experimental Hematology 25(8): 759
Fearnley, D.B.; Mclellan, A.D.; Mannering, S.I.; Hock, B.D.; Hart, D.N.J. 1996: The CMRF-44 antibody identifies blood precursor and functionally mature dendritic cells. Tissue Antigens 48(4-2): 458
Hart, D.N.J.; Fearnley, D.B.; Hock, B.D. 1996: The CMRF-56 mAb identifies dendritic cells after brief culture of human peripheral blood mononuclear cells. Tissue Antigens 48(4-2): 459
Mcguire, R.E.; Searby, C.; Braden, V.V.; Jegathesan, A.; Marra, M.; Mcpherson, J.D.; Ionasescu, V.; Green, E.D. 1997: The CMT2D locus on chromosome 7p Refined genetic localization and high-resolution physical mapping. American Journal of Human Genetics 61(4 Suppl): A239
Milazzo, F.; Coen, M.; Magni, C.; Niero, F.; Quirino, T. 1994: The CMV disease. Giornale di Malattie Infettive e Parassitarie 46(11): 971-979
Alexopoulou, A.N.; Couchman, J.R.; Whiteford, J.R. 2008: The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. Bmc Cell Biology 9: 2
Folkes, B.F.; Sims, A.P.; Cavill, A.P. 1994: The CN-stat A plant growth system for the study of the integration of carbon and nitrogen metabolism and interactions with the environment. Journal of Experimental Botany 45(Suppl ): 50
Krakowski, M.; Owens, T. 1995: The CNS environment controls effector CD4+ T cell cytokine profile in EAE. Journal of Cellular Biochemistry Suppl 1995(21A): 146
Shishko, G.A.; Bogdanovich, N.S.; Perovich, I.V. 1996: The CNS hemorrhagic impairments in preterm newborns in the early neonatal period. Zdravookhranenie (Minsk) 1996(9): 15-17
Ferko, A.P.; Wilson, D.M.; Barbieri, E.J.; Digregorio, G.J.; Mcmichael, R.F.; Bobyock, E. 1996: The CNS interaction of dopamine, cocaine, or cocaethylene with ethanol in mice. FASEB Journal 10(3): A449
D'souza, S.D.; Sadikot, A.F.; Yong, V.W.; Feindel, W. 1996: The CNS myelinating cell Oligodendrocytes A brief history of time. Society for Neuroscience Abstracts 22(1-3): 243
Fink, J.M.; Hirsch, B.; Zheng, C.; Deitz, G.; Hatten, M.E.; Ross, M.R. 1995: The CNS neuronal migration gene, Astrotactin, is mapped to human chromosome band 1q25 by fluorescence in the situ hybridization. American Journal of Human Genetics 57(4 Suppl): A133
Krupp, J.; Vissel, B.; Thomas, C.; Heinemann, S.F.; Westbrook, G.L. 1998: The CO domain of the NR1 subunit is critical for Ca-dependent inactivation of NMDA receptors. Society for Neuroscience Abstracts 24(1-2): 839
Ghosh, A.; Bocian, D.F. 1996: The CO tilting and bending potential energy surface of carbonmonoxyhemes. Biophysical Journal 70(2 Part 2): A220
Olbricht, S.M. 1997: The CO-2 laser Use as an ablative instrument. Arndt, K A , Dover, J S , Olbricht, S M Lasers in cutaneous and aesthetic surgery : 227-261
Wheeland, R.G. 1997: The CO-2 laser Use as an excisional instrument. Arndt, K A , Dover, J S , Olbricht, S M Lasers in cutaneous and aesthetic surgery : 205-226
Motta, G.; Esposito, E.; Cassiano, B. 1996: The CO-2 laser in laryngeal surgery. Verga Scheggi, A M, Martellucci, S, Chester, A N, Pratesi, R NATO ASI Series Series E Applied Sciences; Biomedical optical instrumentation and laser-assisted biotechnology: 257-267
Laier Groeneveld, G.; Baumann, H.J.; Criee, C.P. 1996: The CO-2 recruitment threshold during hyperoxaemia in chronic stable ventilatory failure. European Respiratory Journal Suppl 9(23): 72S
Li, A.; Nattie, E.E. 1996: The CO-2 sensitive respiratory chemoreception region in the rostral ventrolateral medulla identified by a CO-2 diffusion pipette. Society for Neuroscience Abstracts 22(1-3): 1597
Boden, A.G.; Parkes, M.J.; Harris, M.C. 1997: The CO-2 sensitivity of breathing at raised temperatures during hypocapnia in the rat. Journal of Physiology (Cambridge) 501P: 57P-58P
Webb, A.A.R.; Mcainsh, M.R.; Mansfield, T.A.; Hetherington, A.M. 1995: The CO-2 signal transduction chain in stomatal guard cells. Journal of Cellular Biochemistry Suppl 1995(21A): 490
Bychkov, A.; Rogachev, K.; Tishchenko, P.; Nedashkovsky, A.; Carmack, E.; Wong, C.S. 1996: The CO-2 system parameters as indicator of strong tidal mixing in the Pacific Western Subarctic. Caribbean Journal of Science 32(3): 317-318
Wilske,B.; Burgheimer,J.; Karnieli,A.; Zaady,E.; Andreae,M.O.; Yakir,D.; Kesselmeier,J. 2008: The CO2 exchange of biological soil crusts in a semiarid grass-shrubland at the northern transition zone of the Negev desert, Israel. Biogeosciences: 5, 1411-1423
Goldbaum, A.M.; Woog, J.J. 1997: The CO2 laser in oculoplastic surgery. Survey of Ophthalmology 42(3): 255-267
Cooper, G.J.; Boron, W.F. 1997: The CO2 permeability of the AQP1 water channel, expressed in Xenopus oocytes. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 16A
Mcgregor, P., G.; Swales, J.K.; Turner, K. 2008: The CO2 trade balance between Scotland and the rest of the UK Performing a multi-region environmental input-output analysis with limited data. Ecological Economics 66(4): 662-673
Ambruso, D.; Gorlin, J.; Elfath, D.; Menitove, J.; Mcateer, M. 1997: The COBE Trima automated blood component collection system The US clinical experience. Transfusion 37(9 Suppl): 91S
Garcia Villanova Ruiz, R.J.; Gomez Barez, J.A.; Sangrador Fontecha, R. 1993: The COD and absorbance correlation of waters A convenient choice when viability is confirmed. Anales de Bromatologia 44(1): 59-63, 1992
Van Der Loop, F.T.L.; Lemmink, H.H.; Nillesen, W.N.; Brunner, H.G.; Monnens, L.A.H.; Schroder, C.H.; Smeets, H.J.M. 1996: The COL4A4 gene is mutated in familial benign hematuria. Matrix Biology 15(3): 178-179
Kawai, S.I.; Nomura, S.; Fukushima, T.; Harano, K.; Harano, T.; Osawa, G. 1995: The COL4A5 gene in Japanese Alport syndrome patients Spectrum of mutations. Journal of the American Society of Nephrology 6(3): 698
Perin, M.S. 1995: The COOH terminus of multiple synaptotagmins can interact with the neurexins and calmodulin. Molecular Biology of the Cell 6(Suppl ): 60A
Jablonski, S.A.; Yen, T.J. 1996: The COOH-terminal domain of CENP-F mediates cell-cycle dependent targeting to the kinetochore, and is differentially phosphorylated in interphase and mitotic HELA cells. Molecular Biology of the Cell 7(Suppl ): 565A
Miyauchi, Y.; Kato, M.; Tokunaga, F.; Iwai, K. 2008: The COP9/signalosome increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-mediated hypoxia-inducible factor-alpha ubiquitination. Journal of Biological Chemistry 283(24): 16622-16631
Hyne, V.; King, G.J. 1996: The CORE-STORE for Malus Relational database. Case, H J European Malus germplasm 48-49
Guerin, Y.; Chevalier, B.; Durand, P.; Geslin, P.; Saudemont, J.P.; Bedossa, M.; Bassand, J.P.; Valette, B.; Commeau, P.; Grenot, C. 1998: The CORSICA trial Short and mid-term outcome. European Heart Journal 19(ABST Suppl ): 471
Raisinghani, A.; Diaco, N.V.; Sageman, S.W.; Spiess, B.D.; Williams, B.R.; Belott, P.; Ohmori, K.; Demaria, A.N. 1998: The COST study A multicenter trial comparing measurements of cardiac output by thoracic electrical bioimpedance with thermodilution. Journal of the American College of Cardiology 31(2 Suppl A): 430A
Pang, L.; Pitt, A.; Petkova, D.; Knox, A.J. 1998: The COX-1/COX-2 balance in asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 28(9): 1050-1058
Sitarz, R.; Leguit, R., J.; De-Leng, W., W.J.; Polak, M.; Morsink, F., M.; Bakker, O.; Maciejewski, R.; Offerhaus, G.J.han, A.; Milne, A., N. 2008: The COX-2 promoter polymorphism -765 G C is associated with early-onset, conventional and stump gastric cancers. Modern Pathology 21(6): 685-690
Grossman, L.I.; Jaradat, S.A.; Goodman, M.; Schmidt, T.R. 1998: The COX7A gene family Organization, evolution, and function. FASEB Journal 12(8): A1402
Bonne, G.; Carrier, L.; Schwartz, K.; Komajda, M. 1995: The COX8 gene is not the disease gene of the CMH4 locus in familial hypertrophic cardiomyopathy. Journal of Medical Genetics 32(8): 670-671
Zhou, X.-L.; Zhu, B.; Wang, E.-D. 2008: The CP2 domain of leucyl-tRNA synthetase is crucial for amino acid activation and post-transfer editing. Journal of Biological Chemistry 283(52): 36608-36616
Goldfarb, N.E.; Knoepfle, N.; Putnam Evans, C. 1998: The CP43 protein of photosystem II in Synechocystis 6803 Random mutagenesis of the large extrinsic loop. FASEB Journal 12(8): A1443
Connor, L.; Marriott, S. 1994: The CRE and AFT elements play differing roles in Tax transactivation of the HTLV-I LTR. AIDS Research and Human Retroviruses 10(4): 463
Connor, L.M.; Marriott, S.J. 1994: The CRE and ATF elements play differing roles in tax transactivation of the HTLV-1 LTR. Journal of Cellular Biochemistry Suppl 1994(18C): 43
Guo, Z.; Du, X.; Iacovitti, L. 1997: The CRE and CRE-2 motifs are involved in the synergistic induction of the tyrosine hydroxylase gene by acidic fibroblast growth factor and Co-activators. Society for Neuroscience Abstracts 23(1-2): 352
Laurent, J. 1997: The CREGG World Wide Web server wwwcreggorg. Acta Endoscopica 27(2 Suppl): 169-171
Sassone Corsi, Paolo 1993: The CREM gene is a major player in the function of circadian clock. M-S (Medecine Sciences) 9(11): 1253-1255
Murphy, T.H.; Wang, X. 1998: The CREM-derived inducible cAMP-early repressor, ICER, antagonizes transcription mediated by both cAMP- and AP1-response elements. FASEB Journal 12(8): A1323
Baram, T.Z.; Chalmers, D.T.; Chen, C.; Hatalski, C.G.; Foster, A.C.; Schultz, L.; De Souza, E.B. 1997: The CRF-1 receptor mediates the excitatory actions of corticotropin releasing factor in the developing rat brain In vivo evidence using a selective non-peptide receptor antagonist. Society for Neuroscience Abstracts 23(1-2): 1764
Abuirmeileh, A.; Harkavyi, A.; Kingsbury, A.; Lever, R.; Whitton, P.S. 2008: The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide. Journal of the Neurological Sciences 271(1-2): 131-136
Tarnow Mordi, W.; Parry, G.; Moore, J.; Massie, B.; Strang, D.; Newton, S.; Ogston, S. 1992: The CRIB score A method for evaluating the performance of neonatal units. Early Human Development 31(1): 81-82
Tarnow Mondi, W.; Parry, G.; Ogston, S. 1992: The CRIB score A tool for epidemiological studies in very low birthweight infants. Pediatric Research 32(5): 619
Kim, Y.; Starostina, N.G.; Kipreos, E.T. 2008: The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes and Development 22(18): 2507-2519
Wolfe, F. 1996: The CRP in osteoarthritis of the knee or hip is associated with clinical severity. Arthritis and Rheumatism 39(9 Suppl): S173
Cornelissen, M.; Soetaert, P.; Van Aarssen, R.; Stam, M.; Gossele, V.; Dockx, J. 1994: The CRYIAb coding region limits cry mRNA formation in tobacco. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 80
Tenedieva, V.D.; Kulikovsky, V.P.; Lyamin, P.V.; Nepomnyaschi, V.P. 1994: The CSF aldosterone in brain tumors with brain edema. Acta Neurochirurgica. Supplementum 60: 390-394
Sindic, C.J.M. 1997: The CSF in infectious disorders of the CNS PCR detection and intrathecal synthesis of antibodies. Journal of the Neurological Sciences 150(Suppl ): S213
Coffee, P.; Rees, T. 2008: The CSGU: a measure of controllability, stability, globality, and universality attributions. Journal of Sport and Exercise Psychology 30(5): 611-641
Zhang, X.; Musso, T.; Varesio, L.; Modi, W.; Rowe, T.; Ortaldo, J.R.; O'shea, J.J.; Mcvicar, D.W. 1995: The CSK-like leukocyte C-terminal SRC kinase, Lsk, is highly regulated in human peripheral monocytes by IL-3, IL-4, IL-13 and GM-CSF. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 19
Ghai, V.; Gaudet, J. 2008: The CSL transcription factor LAG-1 directly represses hlh-6 expression in C. elegans. Developmental Biology 322(2): 334-344
Peng Guangchun, Han Zaide 1997: The CT features of hepatic cirrhosis in patients with chronic schistosomiasis. Hunan Yike Daxue Xuebao 22(1): 91-92
Falkai, P.; Bogerts, B.; Klieser, E.; Schneider, T.; Scheidt, U.; Bertling, R. 1993: The CT-scan of schizophrenic patients revealing psychotic symptoms when given antidepressants compared to patients not doing so. Pharmacopsychiatry 26(5): 151
Michalski, J.M.; Purdy, J.A.; Harms, W.; Matthews, J.W. 1996: The CT-simulation 3-D treatment planning process. Frontiers of Radiation Therapy and Oncology 29: 43-56
Kong, F.K.; Chen, C.H.C.; Cooper, M.D. 1996: The CT1 cell surface antigen is a marker for recent thymic immigrants in peripheral lymphoid tissues. FASEB Journal 10(6): A1043
Gettings, S.D.; Hintze, K.L.; Bagley, D.M.; Casterton, P.L.; Chudkowski, M.; Curren, R.D.; Demetrulias, J.L.; Dipasquale, L.C.; Earl, L.K. 1994: The CTFA evaluation of alternatives program Phase III. In Vitro Toxicology 7(2): 166
Gould, P.W.; Miller, P.G.G. 1996: The CTI Centre for Biology Network-based information services for biochemicals. Biochemical Society Transactions 24(1): 124S
Sing, A.P.; Ambinder, R.J.; Jensen, M.C.; Batten, W.; Greenberg, P.D. 1995: The CTL response to EBV in Hodgkins lymphoma patients Potential therapeutic implications. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 661
Gause, William C.; Di Zhou, Xia; Chen, S.J.; Morris, Suzanne C.; Finkelman, Fred D.; Linsley, Peter; Urban, Joseph F.; Lu, Pin 1995: The CTLA-4 counter-receptor is required for T cell IL-4 production during the primary but not challenge mucosal immune response to a gastrointestinal parasite. Journal of Cellular Biochemistry Suppl 1995(21A): 165
Saarinen, S.; Broome, U.; Ligers, A.; Olsson, R.; Hultcrantz, R.; Olerup, O. 1998: The CTLA-4 gene is the second susceptibility gene in primary sclerosing cholangitis. European Journal of Immunogenetics 25(Suppl 1): 65
Buzzeti, R.; Nistoci, L.; Pozzilli, P.; Serrano Rios, M.; Larraz, M.T.; Tosi, R.; Giovannini, C. 1995: The CTLA4 microsatellite identifies a new region on chromosome 2 linked to IDDM. Diabetologia 38(Suppl 1): A29
Vrablic, A.S.; Albright, C.D.; Shin, O.K.; Zeisel, S.H. 1996: The CTP Phosphocholine cytidylyltransferase inhibitor 1-O-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces apoptosis in CWSV1 hepatocytes. FASEB Journal 10(3): A180
Gasbarrini, G.; Gasbarrini, A.; Anti, M.; Armuzzi, A.; Franceschi, F.; Lippi, M.E.; Candelli, M.; Paolucci, M.; Cicconi, V.; Danese, S.; Canducci, F.; Cammarota, G.; Pretolani, S.; Stroffolini, T. 1998: The CUE study Prevalence of H pylori infection in a population working at a university hospital. Gut 43(Suppl 2): A43
Xu, X.; Sarikas, A.; Dias-Santagata, D.C.; Dolios, G.; Lafontant, P.J.; Tsai, S.-C.; Zhu, W.; Nakajima, H.; Nakajima, H.O.; Field, L.J.; Wang, R.; Pan, Z.-Q. 2008: The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Molecular Cell 30(4): 403-414
Hilleman, D.E.; Mohiuddin, S.M.; Woodruff, M.P.; Holmberg, M.J.; Pedersen, C.A.; Wurdeman, R.L. 1997: The CURVES trial A pharmacoeconomic evaluation. Pharmacotherapy 17(5): 1107-1108
Mcintosh, J.R.; Vaisberg, E.V.; Ding, R.; West, R.R.; Nurse, P. 1995: The CUT11 gene of S pombe encodes a novel protein that participates in centrosome development and behavior. Molecular Biology of the Cell 6(Suppl ): 364A
Paintal, A.S. 1995: The CV raman medal award lecture New knowledge about exertional breathlessness-use and misuse. Proceedings of the Indian National Science Academy Part B Biological Sciences 61(6): 409-418
Keane, M.P.; Wilke, C.A.; Burdick, M.D.; Morris, S.B.; Glass, M.C.; Strieter, R.M. 1997: The CXC chemokines, KC and IP-10, are important regulators of angiogenic activity in acute lung injury. Journal of Investigative Medicine 45(7): 332A
Ludwig, A.; Petersen, F.; Flad, H.D.; Brandt, E. 1997: The CXC-chemokine NAP-2 acts as a broad range chemoattractant for neutrophils through high and low affinity binding to the two types of IL-8 receptors. Cytokine 9(11): 935
Rieder, G.; Einsiedl, W.; Hatz, R.A.; Walz, A.; Stolte, M.; Enders, G. 1997: The CXC-cytokine ENA-78 correlates strictly with activity of H pylori-associated gastritis. Gut 41(Suppl 1): A14-A15
Niklinski, J.; Furman, M.; Chyczewski, L.; Chyczewska, E.; Laudanski, J. 1996: The CYFRA 21-1 serum test in the pre and postoperative evaluation of squamous cell lung cancer. Proceedings of the American Association for Cancer Research 37: 198
Kawajiri, K.; Nakachi, K.; Imai, K.; Watanabe, J.; Hayashi, S. 1993: The CYP1A1 gene and cancer susceptibility. Critical Reviews in Oncology/Hematology 14(1): 77-87
Bertilsson, L. 1998: The CYP2C19 and CYP2D6 polymorphisms. Experimental and Toxicologic Pathology 50(2): 94
Jeppesen, U.; Rasmussen, B.B.; Brosen, K. 1997: The CYP2C19 catalyzed bioactivation of proguanil is abolished during fluvoxamine intake. European Journal of Clinical Pharmacology 52(Suppl ): A134
Kwon, J.T.; Kim, H.K.; Kim, H.S.; Chung, I.K.; Park, S.H.; Sohn, D.R.; Kim, S.J. 1997: The CYP2E1 polymorphism in a Korean population and hepatocellular carcinoma patients. KOREAN SOCIETY OF PHARMACOLOGY Author Symposium on Current Topics in Pharmacology and Toxicology : 170
Bell, D.R.; Kuo, C.W.S.; Heng, Y.M. 1998: The CYP4A and CYP4B genes cluster in mouse and human. Human and Experimental Toxicology 17(1): 57
Ing, P.S.; Van Dyke, D.L.; Caudill, S.P.; Reidy, J.A.; Chen, A.T.L.; Subcomittee, T.A.mg Cyto2000 1997: The CYTO2000 collaborative study of amniotic fluid cel mosaicism A paradigm for investigating the science and practice of cytogenetics. American Journal of Human Genetics 61(4 Suppl): A51
Lipscombe, D.; Lin, Z. 1996: The Ca channel beta-3-subunit does not significantly affect gating or modulation of alpha-1B currents expressed in oocytes. Society for Neuroscience Abstracts 22(1-3): 5
Fowler, B.C.; Jacobson, H.R.; Breyer, R.M.; Breyer, M.D. 1995: The Ca++-coupled effects of prostaglandin E-2 in the collecting duct are mediated by an EP-1 receptor. Journal of Investigative Medicine 43(Suppl 2): 356A
Van Breemen, C. 1996: The Ca-2+ buffering action of the superficial SR of smooth muscle. Japanese Journal of Pharmacology 71(Suppl 1): 25P
Kapur, A.; Johnston, D. 1996: The Ca-2+ channel blocker Ni-2+ reduces the induction of the Hebbian form of LTP at hippocampal mossy fiber synapses. Society for Neuroscience Abstracts 22(1-3): 1514
Nakata, T.; Sato, S.; Hachisu, M.; Osada, H. 1995: The Ca-2+ current in left ventricular cells in spontaneously hypertensive rats. Japanese Journal of Physiology 45(Suppl 1): S62
Martyn, D.A.; Freitag, C.J.; Gordon, A.M. 1997: The Ca-2+ dependence of dichroism in skeletal fibers containing rhodamine labelled troponin C and the effects of crossbridge inhibition. Biophysical Journal 72(2 Part 2): A283
Suzuki, Y.; Tamura, K.; Koga, T.; Akima, M.; Kato, T.; Nabata, H. 1996: The Ca-2+ overload preventing effect and vasorelaxant properties of CP-060S, a novel cardioprotective drug. Japanese Journal of Pharmacology 71(Suppl 1): 320P